Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARγ2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures
- 31 October 2003
- journal article
- Published by Elsevier BV in Bone
- Vol. 33 (4), 652-659
- https://doi.org/10.1016/s8756-3282(03)00239-4
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Regulation of the osteoblast‐specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathwaysJournal of Cellular Biochemistry, 2003
- The Ability of Statins to Inhibit Bone Resorption Is Directly Related to Their Inhibitory Effect on HMG-CoA Reductase ActivityJournal of Bone and Mineral Research, 2003
- Genetic Analysis of Adipogenesis through Peroxisome Proliferator-activated Receptor γ IsoformsPublished by Elsevier BV ,2002
- Effect of bisphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytesAnnals Of The Rheumatic Diseases, 2002
- Simvastatin Promotes Osteoblast Differentiation and Mineralization in MC3T3-E1 CellsBiochemical and Biophysical Research Communications, 2001
- Pluripotential Marrow Cells Produce Adipocytes when Transplanted into Steroid-Treated MiceConnective Tissue Research, 2000
- Lovastatin Prevents Steroid Induced Adipogenesis and OsteonecrosisClinical Orthopaedics and Related Research, 1997
- Lovastatin 5-year safety and efficacy study. Lovastatin Study Groups I through IVArchives of Internal Medicine, 1993
- Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric studyBone, 1987
- Osteoporosis and the Replacement of Cell Populations of the Marrow by Adipose TissuePublished by Ovid Technologies (Wolters Kluwer Health) ,1971